カテゴリー： QYResearch, 世界

抗うつ薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Antidepressants Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18158）・商品コード：DATA909X18158
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、抗うつ薬の世界市場について調査・分析し、抗うつ薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（三環系抗うつ剤、セロトニン-ノルエピネフリン阻害剤、非定型抗精神病薬、選択的セロトニン再取り込み阻害剤、ベンゾジアゼピン、四環系抗うつ剤、モノアミンオキシダーゼ阻害剤、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の抗うつ薬市場動向
・主要企業別マーケットシェア
・抗うつ薬の種類別市場規模2014-2019
（三環系抗うつ剤、セロトニン-ノルエピネフリン阻害剤、非定型抗精神病薬、選択的セロトニン再取り込み阻害剤、ベンゾジアゼピン、四環系抗うつ剤、モノアミンオキシダーゼ阻害剤、その他）
・抗うつ薬の用途別市場規模2014-2019
（病院、クリニック、その他）
・抗うつ薬の北米市場：主要企業・種類別/用途別市場規模
・抗うつ薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・抗うつ薬の中国市場：主要企業・種類別/用途別市場規模
・抗うつ薬の日本国内市場：主要企業・種類別/用途別市場規模
・抗うつ薬の東南アジア市場：主要企業・種類別/用途別市場規模
・抗うつ薬のインド市場：主要企業・種類別/用途別市場規模
・抗うつ薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Pfizer、AstraZeneca、Eli Lilly and Company、Novartis、GlaxoSmithKline、Otsuka Pharmaceutical、Abbott Laboratories、Gedeon Richter、Janssen Pharmaceuticals、Lupin Pharmaceuticals、Luye Pharma、MSI Methylation Sciences、Naurex、SK Biopharmaceuticals）
・抗うつ薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.In 2018, the global Antidepressants Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer
AstraZeneca
Eli Lilly and Company
Novartis
GlaxoSmithKline
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals

Market segment by Type, the product can be split into
Tricyclic Antidepressants
Serotonin-norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antidepressants Drugs status, future forecast, growth opportunity, key market and key players.
To present the Antidepressants Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antidepressants Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antidepressants Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tricyclic Antidepressants
1.4.3 Serotonin-norepinephrine Inhibitors
1.4.4 Atypical Antipsychotics
1.4.5 Selective Serotonin Reuptake Inhibitors
1.4.6 Benzodiazepines
1.4.7 Tetracyclic Antidepressants
1.4.8 Monoamine Oxidase Inhibitors
1.4.9 Others
1.5 Market by Application
1.5.1 Global Antidepressants Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Antidepressants Drugs Market Size
2.2 Antidepressants Drugs Growth Trends by Regions
2.2.1 Antidepressants Drugs Market Size by Regions (2019-2025)
2.2.2 Antidepressants Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Antidepressants Drugs Market Size by by Players
3.1.1 Global Antidepressants Drugs Revenue by by Players (2014-2019)
3.1.2 Global Antidepressants Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Antidepressants Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antidepressants Drugs Key Players Head office and Area Served
3.3 Key Players Antidepressants Drugs Product/Solution/Service
3.4 Date of Enter into Antidepressants Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Antidepressants Drugs Market Size by Type (2014-2019)
4.2 Global Antidepressants Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Antidepressants Drugs Market Size (2014-2019)
5.2 Antidepressants Drugs Key Players in North America
5.3 North America Antidepressants Drugs Market Size by Type
5.4 North America Antidepressants Drugs Market Size by Application

6 Europe
6.1 Europe Antidepressants Drugs Market Size (2014-2019)
6.2 Antidepressants Drugs Key Players in Europe
6.3 Europe Antidepressants Drugs Market Size by Type
6.4 Europe Antidepressants Drugs Market Size by Application

7 China
7.1 China Antidepressants Drugs Market Size (2014-2019)
7.2 Antidepressants Drugs Key Players in China
7.3 China Antidepressants Drugs Market Size by Type
7.4 China Antidepressants Drugs Market Size by Application

8 Japan
8.1 Japan Antidepressants Drugs Market Size (2014-2019)
8.2 Antidepressants Drugs Key Players in Japan
8.3 Japan Antidepressants Drugs Market Size by Type
8.4 Japan Antidepressants Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Antidepressants Drugs Market Size (2014-2019)
9.2 Antidepressants Drugs Key Players in Southeast Asia
9.3 Southeast Asia Antidepressants Drugs Market Size by Type
9.4 Southeast Asia Antidepressants Drugs Market Size by Application

10 India
10.1 India Antidepressants Drugs Market Size (2014-2019)
10.2 Antidepressants Drugs Key Players in India
10.3 India Antidepressants Drugs Market Size by Type
10.4 India Antidepressants Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Antidepressants Drugs Market Size (2014-2019)
11.2 Antidepressants Drugs Key Players in Central & South America
11.3 Central & South America Antidepressants Drugs Market Size by Type
11.4 Central & South America Antidepressants Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antidepressants Drugs Introduction
12.1.4 Pfizer Revenue in Antidepressants Drugs Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antidepressants Drugs Introduction
12.2.4 AstraZeneca Revenue in Antidepressants Drugs Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antidepressants Drugs Introduction
12.3.4 Eli Lilly and Company Revenue in Antidepressants Drugs Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antidepressants Drugs Introduction
12.4.4 Novartis Revenue in Antidepressants Drugs Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antidepressants Drugs Introduction
12.5.4 GlaxoSmithKline Revenue in Antidepressants Drugs Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Otsuka Pharmaceutical
12.6.1 Otsuka Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antidepressants Drugs Introduction
12.6.4 Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2014-2019)
12.6.5 Otsuka Pharmaceutical Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antidepressants Drugs Introduction
12.7.4 Abbott Laboratories Revenue in Antidepressants Drugs Business (2014-2019)
12.7.5 Abbott Laboratories Recent Development
12.8 Gedeon Richter
12.8.1 Gedeon Richter Company Details
12.8.2 Company Description and Business Overview
12.8.3 Antidepressants Drugs Introduction
12.8.4 Gedeon Richter Revenue in Antidepressants Drugs Business (2014-2019)
12.8.5 Gedeon Richter Recent Development
12.9 Janssen Pharmaceuticals
12.9.1 Janssen Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Antidepressants Drugs Introduction
12.9.4 Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2014-2019)
12.9.5 Janssen Pharmaceuticals Recent Development
12.10 Lupin Pharmaceuticals
12.10.1 Lupin Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Antidepressants Drugs Introduction
12.10.4 Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2014-2019)
12.10.5 Lupin Pharmaceuticals Recent Development
12.11 Luye Pharma
12.12 MSI Methylation Sciences
12.13 Naurex
12.14 SK Biopharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Antidepressants Drugs Key Market Segments
Table Key Players Antidepressants Drugs Covered
Table Global Antidepressants Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Tricyclic Antidepressants Figures
Table Key Players of Tricyclic Antidepressants
Figuer Serotonin-norepinephrine Inhibitors Figures
Table Key Players of Serotonin-norepinephrine Inhibitors
Figuer Atypical Antipsychotics Figures
Table Key Players of Atypical Antipsychotics
Figuer Selective Serotonin Reuptake Inhibitors Figures
Table Key Players of Selective Serotonin Reuptake Inhibitors
Figuer Benzodiazepines Figures
Table Key Players of Benzodiazepines
Figuer Tetracyclic Antidepressants Figures
Table Key Players of Tetracyclic Antidepressants
Figuer Monoamine Oxidase Inhibitors Figures
Table Key Players of Monoamine Oxidase Inhibitors
Figuer Others Figures
Table Key Players of Others
Table Global Antidepressants Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Antidepressants Drugs Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Antidepressants Drugs Report Years Considered
Figure Global Antidepressants Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Antidepressants Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Antidepressants Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Antidepressants Drugs Market Share by Regions 2014-2019
Figure Global Antidepressants Drugs Market Share by Regions 2014-2019
Figure Global Antidepressants Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Antidepressants Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Antidepressants Drugs Market Share by by Players (2014-2019)
Figure Global Antidepressants Drugs Market Share by by Players in 2018
Table Global Antidepressants Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Antidepressants Drugs Product/Solution/Service
Table Date of Enter into Antidepressants Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Antidepressants Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Antidepressants Drugs Market Size Share by Type (2014-2019)
Figure Global Antidepressants Drugs Market Size Market Share by Type (2014-2019)
Table Global Antidepressants Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Antidepressants Drugs Market Size Share by Application (2014-2019)
Figure Global Antidepressants Drugs Market Size Market Share by Application (2014-2019)
Figure Global Antidepressants Drugs Revenue Market Share by Application in 2018
Figure North America Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Antidepressants Drugs Market Share (2018-2019)
Table North America Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Antidepressants Drugs Market Share by Type 2014-2019
Table North America Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Antidepressants Drugs Market Share by Application 2014-2019
Figure Europe Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Antidepressants Drugs Market Share (2018-2019)
Table Europe Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Antidepressants Drugs Market Share by Type 2014-2019
Table Europe Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Antidepressants Drugs Market Share by Application 2014-2019
Figure China Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Antidepressants Drugs Market Share (2018-2019)
Table China Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table China Antidepressants Drugs Market Share by Type 2014-2019
Table China Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table China Antidepressants Drugs Market Share by Application 2014-2019
Figure Japan Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Antidepressants Drugs Market Share (2018-2019)
Table Japan Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Antidepressants Drugs Market Share by Type 2014-2019
Table Japan Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Antidepressants Drugs Market Share by Application 2014-2019
Figure Southeast Asia Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Antidepressants Drugs Market Share (2018-2019)
Table Southeast Asia Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Antidepressants Drugs Market Share by Type 2014-2019
Table Southeast Asia Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Antidepressants Drugs Market Share by Application 2014-2019
Figure India Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Antidepressants Drugs Market Share (2018-2019)
Table India Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table India Antidepressants Drugs Market Share by Type 2014-2019
Table India Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table India Antidepressants Drugs Market Share by Application 2014-2019
Figure Central & South America Antidepressants Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Antidepressants Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Antidepressants Drugs Market Share (2018-2019)
Table Central & South America Antidepressants Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Antidepressants Drugs Market Share by Type 2014-2019
Table Central & South America Antidepressants Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Antidepressants Drugs Market Share by Application 2014-2019
Table Pfizer Company Details
Table Pfizer Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Novartis Company Details
Table Novartis Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Otsuka Pharmaceutical Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Otsuka Pharmaceutical Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Gedeon Richter Company Details
Table Gedeon Richter Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Gedeon Richter Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Gedeon Richter Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Lupin Pharmaceuticals Company Details
Table Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business 2014-2019 (Million US$)
Figure Lupin Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2014-2019)
Table Lupin Pharmaceuticals Recent Development
Table Luye Pharma Company Details
Table MSI Methylation Sciences Company Details
Table Naurex Company Details
Table SK Biopharmaceuticals Company Details
Table Global Antidepressants Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Antidepressants Drugs Market Size Share by Regions (2019-2025)
Figure Global Antidepressants Drugs Market Size Share by Regions in 2025
Figure North America Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Antidepressants Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Antidepressants Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Antidepressants Drugs Market Size by Product (2019-2025)
Figure Global Antidepressants Drugs Market Size by Product in 2025
Table Global Antidepressants Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Antidepressants Drugs Market Size by Application (2019-2025)
Figure Global Antidepressants Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、AstraZeneca、Eli Lilly and Company、Novartis、GlaxoSmithKline、Otsuka Pharmaceutical、Abbott Laboratories、Gedeon Richter、Janssen Pharmaceuticals、Lupin Pharmaceuticals、Luye Pharma、MSI Methylation Sciences、Naurex、SK Biopharmaceuticals

★調査レポート[抗うつ薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18158)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗うつ薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 中枢神経系疾患薬品の世界市場：規模・現状・予測2019-2025
    DATA909X18410 / QYResearch / 2019年11月25日 / ※当調査レポートでは、中枢神経系疾患薬品の世界市場について調査・分析し、中枢神経系疾患薬品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、抗躁薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の中枢神経系疾患薬品市場動向 ・主要企業別マーケットシェア ・中枢神経系疾患薬品の種類別市場規模2014-2019 （抗うつ薬、抗不安薬、抗躁薬、その他） ・中枢神経系疾患薬品の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・中枢神経系疾患薬品の北米市場：主要企業・種類別/用途別市場規模 ・中枢神経系疾患薬品のヨーロッパ市場：主要企業・種類別/用途別市場規模...A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Drugs for Central Nervous System Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Central Nervous System Diseases development in North America, Europe, China, Japan,...
  • そう痒治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18875 / QYResearch / 2019年11月25日 / ※当調査レポートでは、そう痒治療薬の世界市場について調査・分析し、そう痒治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（局所、経口、非経口）、用途別（血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のそう痒治療薬市場動向 ・主要企業別マーケットシェア ・そう痒治療薬の種類別市場規模2014-2019 （局所、経口、非経口） ・そう痒治療薬の用途別市場規模2014-2019 （血液性そう痒症、腫瘍性そう痒症、腎そう痒症、内分泌性掻そう痒症、胆汁うっ滞性そう痒症） ・そう痒治療薬の北米市場：主要企業・種類別/用途別市場規模 ・そう痒治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs.The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other forms of drug delivery methods. Moreover, transdermal drug delivery systems increase the bioavailability of active ingredients and prevent destructive hepatic first-pass metabolism. However, the delivery of small and lipophilic drugs is difficult through the method of drug development. In 2018, the global Pruritus Drugs market size was xx million US$ and it is expected to...
  • 気管支拡張薬の世界市場：規模・現状・予測2019-2025
    DATA909X18244 / QYResearch / 2019年11月25日 / ※当調査レポートでは、気管支拡張薬の世界市場について調査・分析し、気管支拡張薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、去痰薬、その他の薬物）、用途別（病院、研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の気管支拡張薬市場動向 ・主要企業別マーケットシェア ・気管支拡張薬の種類別市場規模2014-2019 （抗生物質、去痰薬、その他の薬物） ・気管支拡張薬の用途別市場規模2014-2019 （病院、研究所、クリニック、その他） ・気管支拡張薬の北米市場：主要企業・種類別/用途別市場規模 ・気管支拡張薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently. The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists...
  • 起立性低血圧治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18788 / QYResearch / 2019年11月25日 / ※当調査レポートでは、起立性低血圧治療薬の世界市場について調査・分析し、起立性低血圧治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の起立性低血圧治療薬市場動向 ・主要企業別マーケットシェア ・起立性低血圧治療薬の種類別市場規模2014-2019 （ミドドリン、ノーテラ（ドロキシドパ）、フルドロコルチゾン、その他の薬物） ・起立性低血圧治療薬の用途別市場規模2014-2019 （病院、医学研究所、クリニック、その他） ・起立性低血圧治療薬の北米市場：主要企業・種類別/用途別市場規模 ・起立性低血圧治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the...
  • クリプトコッカス薬の世界市場：規模・現状・予測2019-2025
    DATA909X18352 / QYResearch / 2019年11月25日 / ※当調査レポートでは、クリプトコッカス薬の世界市場について調査・分析し、クリプトコッカス薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アムホテリシンB、フルシトシン、フルコナゾール、その他）、用途別（病院薬局、小売薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のクリプトコッカス薬市場動向 ・主要企業別マーケットシェア ・クリプトコッカス薬の種類別市場規模2014-2019 （アムホテリシンB、フルシトシン、フルコナゾール、その他） ・クリプトコッカス薬の用途別市場規模2014-2019 （病院薬局、小売薬局、その他） ・クリプトコッカス薬の北米市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.In 2018, the global Cryptococcosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 食道癌治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18452 / QYResearch / 2019年11月25日 / ※当調査レポートでは、食道癌治療薬の世界市場について調査・分析し、食道癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他）、用途別（標的療法、化学療法）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の食道癌治療薬市場動向 ・主要企業別マーケットシェア ・食道癌治療薬の種類別市場規模2014-2019 （フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他） ・食道癌治療薬の用途別市場規模2014-2019 （標的療法、化学療法） ・食道癌治療薬の北米市場：主要企業・種類別/用途別市場規模 ・食道癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.Various combinations of drugs such as fluorouracil, cisplatin, docetaxel, and carboplatin are involved in standard chemotherapy regimens for the treatment of esophageal cancer. These drugs are selected based on adverse drug reactions and cancer subtypes. To ensure patient access to available therapeutics, governments in developed countries are introducing reimbursement...
  • 鼻ポリープ薬の世界市場：規模・現状・予測2019-2025
    DATA909X18738 / QYResearch / 2019年11月25日 / ※当調査レポートでは、鼻ポリープ薬の世界市場について調査・分析し、鼻ポリープ薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の鼻ポリープ薬市場動向 ・主要企業別マーケットシェア ・鼻ポリープ薬の種類別市場規模2014-2019 （コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他） ・鼻ポリープ薬の用途別市場規模2014-2019 （病院、クリニック、その他） ・鼻ポリープ薬の北米市場：主要企業・種類別/用途別市場規模 ・鼻ポリープ薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.In 2018, the global Nasal Polyps Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on...
  • 体部白癬用薬の世界市場：規模・現状・予測2019-2025
    DATA909X19035 / QYResearch / 2019年11月25日 / ※当調査レポートでは、体部白癬用薬の世界市場について調査・分析し、体部白癬用薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗真菌剤、ステロイド、抗感染性組み合わせ）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の体部白癬用薬市場動向 ・主要企業別マーケットシェア ・体部白癬用薬の種類別市場規模2014-2019 （抗真菌剤、ステロイド、抗感染性組み合わせ） ・体部白癬用薬の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・体部白癬用薬の北米市場：主要企業・種類別/用途別市場規模 ・体部白癬用薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tinea Corporis Drugs development in North America,...

    • ◆H&Iグローバルリサーチのお客様（例）◆